Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Closed Loop Medicine and Pharmanovia enter a co-development partnership for precision medicinerug plus software therapy products
Thursday, May 18, 2023Closed Loop Medicine Ltd a leading TechBio company developing combination prescription drug plus software therapy products that enable personalized dose optimization and Pharmanovia a global pharmaceutical company that commercializes novel medicines...
New Menarini Silicon Biosystems partnership with Alivio Health expands patient access to CELLSEARCH® liquid biopsy tests
Thursday, May 18, 2023Menarini Silicon Biosystems just signed a partnership with Alivio Health to provide preferred access to their clients and members to the minimally invasive CELLSEARCH CTC tests so that more cancer patients may benefit from realtime information on dis...
Chinook Therapeutics Announces Partnership with Ionis to Develop Antisense Therapy for Rare, Severe Chronic Kidney Disease
Wednesday, May 17, 2023Chinook Therapeutics Inc Nasdaq KDNY today announced it has entered a collaboration agreement with Ionis Pharmaceuticals Inc for the discovery development and commercialization of an antisense oligonucleotide ASO therapy for a rare severe chronic kid...
IRLAB Therapeutics and the McQuade Center for Strategic Research and Development Enter into Agreement to Evaluate IRLAB’s Neuropsychiatric Programs IRL757 and IRL942
Wednesday, May 17, 2023IRLAB Therapeutics AB Nasdaq Stockholm IRLAB A a company discovering and developing novel treatments for Parkinsons disease today announced the signing of an agreement with the McQuade Center for Strategic Research and Development LLC MSRD a member o...
Cambrex Completes Expansion of Snapdragon Chemistry Facility in Waltham, Massachusetts
Wednesday, May 17, 2023Cambrex a leading global contract development and manufacturing organization CDMO providing drug substance drug product and analytical services across the entire drug lifecycle today announced that Snapdragon Chemistry has completed the second phase...
SonoThera™ Announces Research Collaboration with Janssen Pharmaceuticals, Inc. to Accelerate Development of Ultrasound-Guided Nonviral Gene Therapy Platform
Tuesday, May 16, 2023SonoThera a biotechnology company dedicated to treating the root cause of human diseases through genetic therapy announced today that it entered into a research collaboration agreement with Janssen Pharmaceuticals Inc Janssen one of the Pharmaceutica...
Sony and Astellas Enter into Collaborative Research Agreement to Discover a Novel ADC Platform for the Oncology Field
Tuesday, May 16, 2023Sony Corporation President and CEO Kimio Maki Sony and Astellas Pharma Inc TSE President and CEO Naoki Okamura Astellas today announced that they have entered into a collaborative research agreement to discover a novel AntibodyDrug Conjugate ADC pla...
Rona Therapeutics and Keymed Biosciences Announce Collaboration to Discover and Develop First-in-class siRNA Therapeutics
Monday, May 15, 2023Rona Therapeutics Inc Rona and Keymed Biosciences Keymed HKEX today announced a collaboration to jointly discover and develop firstinclass siRNA therapeutics for Glomerulonephritis also referred as severe kidney diseases The collaboration will lever...
Bavarian Nordic Completes Acquisition of Travel Vaccine Portfolio from Emergent BioSolutions
Monday, May 15, 2023With the closing of this transaction Bavarian Nordic acquires two marketed vaccines Vivotif for the prevention of typhoid fever and Vaxchora for the prevention of cholera as well as a Phase vaccine candidate for the prevention of Chikungunya virus...
SERB Pharmaceuticals and SFJ Pharmaceuticals announce a U.S. partnership for bentracimab, a ticagrelor reversal agent
Friday, May 12, 2023SERB Pharmaceuticals a global specialty pharmaceutical company and SFJ Pharmaceuticals a global drug development company announce that SERB has acquired exclusive US rights to the ticagrelor reversal agent bentracimab from SFJ
